COMMUNIQUÉS West-GlobeNewswire
-
Lenny Peters Cup Turns High Point, N.C., Into an International Rowing Destination
27/10/2026 -
Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026
27/10/2026 -
Ozari Health Named Cheapest Place to Buy Compounded Tirzepatide Online for 2026
27/10/2026 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2026
27/10/2026 -
UK health tech pioneer Patients Know Best launches global expansion at HLTH Las Vegas
27/10/2026 -
Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress
27/10/2026 -
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile
27/10/2026 -
Four Years After St. Paul Acquisition, Pro-Tech Design & Manufacturing Shows Medtech Consolidation Doesn't Have to Mean Disruption
27/10/2026 -
Canadians Want Professional Women’s Sport. Most Fans Don’t Know Where to Find it.
27/10/2026 -
Les Canadiens souhaitent assister à des événements sportifs féminins professionnels. La plupart des amateurs ignorent cependant où les trouver.
27/10/2026 -
1104Health and Johns Hopkins Researchers Present Data on Physician Collaboration Across Community and Academic Oncology
27/10/2026 -
AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes
27/10/2026 -
AscellaHealth Executive Manager Wins 2026 Herizon Award, Recognizing Established Leadership in Team and Department Transformation
27/10/2026 -
National NUCCA doctors highlight importance of spinal health for daily function, better quality of life during World Spine Day observance
27/10/2026 -
Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline
27/10/2026 -
Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development
27/10/2026 -
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
27/10/2026 -
Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH
27/10/2026 -
Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
27/10/2026
Pages